InvestorsHub Logo
Followers 95
Posts 4214
Boards Moderated 1
Alias Born 11/05/2014

Re: None

Tuesday, 11/21/2023 9:12:10 AM

Tuesday, November 21, 2023 9:12:10 AM

Post# of 171
Alon Ben-Noon. CEO

Join us in spreading Hope for those affected by ALS!

In December, NeuroSense will unveil the clinical Top-line results of the Paradigm study, marking a major turning point in the fight against ALS. We're committed to sharing all results from this groundbreaking clinical trial with the ALS community.

Please help us reach as many as possible - share this message with your loved ones. Together, we can make a difference. 🩵 #ALS #HopeForACure
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRSN News